OC-0551: Advantage of IMPT over IMRT in treatment of gynaecological cancer with para-aortic nodal involvement  by Van de Sande, M. et al.
ESTRO 35 2016                                                                                                                                                    S263 
______________________________________________________________________________________________________ 
 
 
 
 
 
Conclusion: This study has shown that accounting for the 
effects of the magnetic field during treatment planning 
allows for design of clinically acceptable lung SBRT 
treatments with a MR-linac. Furthermore, it was found that 
the ability of real-time tumor tracking to decrease dose 
exposure to healthy tissue was not degraded by a magnetic 
field. 
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Purpose or Objective: Combining the capabilities of high 
resolution soft tissue MR imaging and intensity modulated 
radiation therapy into a hybrid device has the potential to 
increase the accuracy of radiotherapy. However, it is known 
that the magnetic field of the MR manipulates the trajectory 
of the secondary electrons and leads to a deviation of dose 
especially at the interfaces between high and low density 
materials. This study aims to introduce a routine for the 
evaluation of magnetic field effects to dose delivery and plan 
optimization using Monte Carlo simulations. 
 
Material and Methods: An EGSnrc Monte Carlo environment, 
based on the egs++ class library, was developed which can be 
used for the simulation of IMRT treatment plans in the 
presence of a magnetic field, based on patient CT data. A 
routine for the processing of treatment planning parameters 
and Monte Carlo simulation data was implemented into the 
in-house open source treatment planning system matRad. In 
order to basically validate the implementation, dose 
distributions at 0 T were compared against collapsed cone 
calculations by the treatment planning system RayStation. 
The effect of a magnetic field to the dose distribution was 
investigated for simulations in a porcine lung phantom. Based 
on Monte Carlo simulations of patient specific beamlets, plan 
optimization was performed and analyzed.  
 
Results: Comparison showed that the Monte Carlo simulations 
of IMRT plans at 0 T are in good agreement with RayStation 
dose calculations. The effect of a 1.5 T lateral magnetic field 
on the dose distribution showed distinct alteration in tumor 
dose. Differences appear to be less when an opposing field 
technique is used. It could further be proven that the routine 
is capable of performing plan optimization based on Monte 
Carlo simulated beamlets in the presence of a magnetic field 
(see figure 1).  
 
Conclusion: A routine for dose calculation of IMRT plans with 
EGSnrc and for plan optimization based on Monte Carlo 
simulated beamlets using the in-house planning system 
matRad was developed. This implementation provides the 
possibility to analyze the effects of a magnetic field during 
radiotherapy in detail. Additionally it enables the 
investigation of optimization strategies for an MRI-LINAC 
system.  
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Purpose or Objective: High costs and limited capacity in 
proton therapy requires prioritizing according to expected 
benefit. The aim of this work is to quantify the clinical 
advantage of robust intensity-modulated proton therapy 
(IMPT) in terms of sparing of organs at risk (OARs) for three 
target volumes in treatment of gynaecological cancers 
compared with state-of-the-art intensity-modulated photon 
therapy (IMRT), and to evaluate for which target volume the 
benefit would justify the use of IMPT. 
 
Material and Methods: Three target volumes were included: 
pelvic region (primary or postoperative treatment; N=10, 6 
with boost dose), pelvic and para-aortic region (N=6, all with 
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boost dose), para-aortic region alone (para-aortic recurrence, 
N=5, all with boost dose). Robust IMPT (minimax method) and 
20-beam IMRT plans were generated with an in-house 
developed system for automated treatment planning. 
Prescription dose was 48.6 Gy with or without a simultaneous 
integrated boost to 58.05 Gy. IMPT and IMRT plans were 
made for wide (15 mm primary CTV/7 mm nodal CTV) and 
small (5/2 mm) CTV-PTV margins. IMPT plans included range 
robustness of 3% and setup robustness of 2 mm assuming 
online setup correction and adaptive radiotherapy. Relevant 
dose-volume parameters of OARs were used to compare both 
techniques. 
 
Results: IMPT reduced the dose in all OARs for similar target 
coverage (>99%). The benefit of IMPT was higher in the lower 
dose region than in the higher dose region. Figure 1 compares 
OAR dose-volume parameters per patient. For treatment of 
the pelvic region, the dose in pelvic bones was on average 
27% lower with IMPT; and in femoral heads 5% lower. For 
treatment of pelvic and para-aortic region, kidney and spinal 
cord dose was lower for IMPT (left kidney 1.1 Gy vs 7.8 Gy; 
right kidney 2.4 Gy vs 11.8 Gy; spinal cord 14.5 Gy vs 28.0 
Gy). For the para-aortic region alone an important advantage 
in favour of IMPT was seen (left kidney 4.4 Gy vs 38.6 Gy; 
right kidney 0.5 Gy vs 5.8 Gy; spinal cord 29.2 Gy vs 39.7 Gy), 
see Table 1. For all target volumes clinically relevant 
reductions in V15Gy for the bowelbag were found, reducing 
V15Gy by 153 cc, 1231 cc, and 523 cc, respectively. 
Differences in dose to most OARs were similar for wide and 
small margins, while the advantage of IMPT was more 
pronounced for rectum, bladder, and sigmoid using small 
margins. 
 
 
 
Conclusion: For all gynaecological target volumes, IMPT 
reduced the dose to all OARs compared with IMRT, mainly in 
the lower dose region and for both wide and small margins. 
Considerable reduction of the bowel volume receiving 15 Gy 
or more was seen. The greatest and clinically relevant 
advantage of IMPT was found for treatment of macroscopic 
disease in the para-aortic region, justifying the use of proton 
therapy for this indication. 
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Purpose or Objective: Proton beam therapy represents a 
promising modality for left breast irradiation due to 
negligible dose to non-target volume, as heart and lung. 
However skin toxicity and poor cosmesis inherent to protons 
physical properties are of major concern. Radiation-induced 
skin toxicity (RIST) is a side effect impacting on the quality of 
life in breast cancer patients treated with radiation therapy. 
Purpose of the present study is twofold: a) to develop a 
normal tissue complication probability (NTCP) model of 
severe acute RIST in BC patients treated with conventional 
three-dimensional conformal radiotherapy (3DCRT) and b) to 
use the implemented skin NTCP model to guide breast proton 
therapy plan optimization. 
 
Material and Methods: We evaluated 140 consecutive BC 
patients undergoing 3DCRT after breast conserving surgery in 
a prospective study assessing acute RIST. Acute RIST was 
classified according to the RTOG scoring system. Dose-surface 
histograms (DSHs) of the body-structure in the breast region 
were extracted. DSHs of the body were considered as 
representative of the irradiation in epidermis and dermis 
layers and extracted by an in-house developed library using 
the relative complement in the body of its 3D erosion defined 
by a spherical structuring element of radius r = 3 mm 
(assumed as mean skin thickness). On such shell, the absolute 
dose-volume histogram was regularly computed and then 
divided by r to obtain the DSH. NTCP modeling by Lyman-
Kutcher-Burman (LKB) recast for DSHs and using bootstrap 
resampling techniques was performed. Five randomly 
selected left BC patients were then replanned using proton 
pencil beam scanning (PBS). PBS plans were obtained to 
ensure appropriate target coverage (90% 50 Gy(RBE) 
prescription dose to the 90% breast) and heart-lung sparing. 
Different planning objectives for skin were used (Table 1) and 
two different beam set-ups were tested. The proton plan 
body DSHs were extracted and the corresponding NTCP values 
calculated. 
